Coherus Oncology, Inc. Common Stock
CHRS
CHRS
93 hedge funds and large institutions have $627M invested in Coherus Oncology, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 44 increasing their positions, 24 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
-13
Holders Change %
-12.26%
% of All Funds
2.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
44
Reduced
24
Closed
21
Calls
$1.43M
Puts
$1.92M
Net Calls
-$491K
Net Calls Change
-$3.57M
Top Buyers
1 |
Temasek Holdings
Singapore
|
$87.5M |
2 |
Wellington Management Group
Boston,
Massachusetts
|
$83.9M |
3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$16.2M |
4 |
State Street
Boston,
Massachusetts
|
$25M |
5 |
![]()
JPMorgan Chase & Co
New York
|
$23.6M |